Abstract
Serum fucose determinations were performed on 19 patients with “stable” or “inactive” malignancies, 33 patients with “active” malignancies, and 14 “normals.” A significant difference in the values between “normal” and “stable” patients and those with “active” cancer is shown. A role for this relatively simple serological test for diagnosing and following metastatic cancer is suggested.
| Original language | English |
|---|---|
| Pages (from-to) | 39-44 |
| Number of pages | 6 |
| Journal | Journal of Surgical Oncology |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1978 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer
- diagnosis
- fucose
Fingerprint
Dive into the research topics of 'Serum fucose as a monitor for recurrent malignancy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver